GlassScriptPhysician profile
Trang Pham
NPI 1932596681
$3,714.06
in general payments reported to CMS, 2019-2025
14 companies · $99.49 in 2025
The $99.49 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $208 · 2021: $724 · 2022: $1,774 · 2023: $434 · 2024: $262 · 2025: $99.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Gift: $48.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.22 |
| Gift | $48.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,057.96 | 2022 | |
| Coloplast Corp | $743.53 | 2019-2024 | Porges Coloplast |
| Axonics, INC. | $650.45 | 2021-2024 | Bulkamid |
| Medtronic, INC. | $517.78 | 2021-2025 | Interstim |
| Caldera Medical, INC | $212.13 | 2023 | Desara |
| Medtronic USA, INC. | $108.26 | 2020 | |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Urovant Sciences INC | $98.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.00 | 2022 | |
| Boston Scientific Corporation | $61.04 | 2021-2022 | |
| Abbvie INC. | $34.91 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $31.19 | 2023 | |
| Urogen Pharma, INC. | $17.11 | 2025 | |
| Verity Pharmaceuticals INC. | $16.31 | 2023 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trang Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.